Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
J.P. Morgan
Biotech
Inside Incubate’s battles for biotech on Capitol Hill
John Stanford is making the case that the success of the domestic biotech industry is an issue of national security and economic competitiveness.
Will Maddox
Mar 27, 2026 8:00am
Biopharma VC activity suggests growth has returned
Jul 29, 2024 10:26am
J.P. Morgan arm secures $500M+ for first biotech-only fund
Jun 14, 2024 10:37am
Mindstate takes trip to clinic with first AI-derived psychedelic
Mar 13, 2024 9:00am
JPM's private capital team ‘actively looking’ at psychedelics
Feb 28, 2024 7:00am
Rubius execs depart as the walls close in—Chutes & Ladders
Nov 4, 2022 9:30am
